Navigating the Transition: From CMO Manufacturing to In-House Manufacturing in Cell and Gene Therapy Production

Time: 9:00 am
day: Conference Day One


  • Discussing the benefits of having additional in-house manufacturing capabilities alongside with CMO for cell and gene therapy production
  • Highlighting the need for flexibility and control in the manufacturing process for cell and gene therapies
  • Emphasizing the unique challenges and opportunities of constructing a largescale cell and gene therapy facility